Editas stock reddit. Business, Economics, and Finance.
Editas stock reddit In midday trading on the stock market today, Editas stock led the pack, skyrocketing 40. The company achieved preclinical proof of concept for in Editas Medicine, Inc. Crypto Editas Medicine (EDIT) has announced significant progress in its gene editing programs, highlighting new preclinical proof of concept data and strategic priorities through 2027. 00M. 21 votes, 22 comments. The company achieved ~40% editing of the HBG1/2 promoter site using their proprietary targeted lipid nanoparticle delivery system, resulting in 20% HbF expressing human red blood cells. The company will be featured in fireside chat sessions at Guggenheim's Inaugural Healthcare Innovation Conference on November 12 at 4:00 p. Michaels, M. Posted by u/StockConsultant - 1 vote and no comments Business, Economics, and Finance. Feb. 978 subscribers in the EditasMedicine community. If there's more behind Hack's departure that should Editas ended the year with cash, cash equivalents, and marketable securities of $369 million, good for at least 24 months of funding for operating expenses and capital expenditures -- or, Find the latest Editas Medicine, Inc. r/EditasMedicine A chip A close button 451K subscribers in the WallStreetbetsELITE community. CRISPR technology and stock prices discussions of $EDIT 1. Editas is eligible for roughly $700 million in milestone payments through 2020, and if any drugs are approved, EDIT will be eligible to receive royalties. 24M. Financial Markets and Fintech News Forex broker comparison and trading education Free Telegram: PipPost Editas Medicine (Nasdaq: EDIT) reported its Q2 2024 results and provided business updates. Members Online. Crypto 983 subscribers in the EditasMedicine community. I did this for my BABA position and it saved me. Once, we would Buy, Sell, and Trade memes with Karma. Get app Unofficial - Editas Medicine Message Board on Reddit. We don't moderate (much). P 983 subscribers in the EditasMedicine community. The 737 subscribers in the Docstocks community. (EDIT) stock news and headlines to help you in your trading and investing decisions. Crypto Business, Economics, and Finance. I'm really surprised Editas' CMO would make such a claim and that NPR didn't do their due diligence to confirm it was true or not. CRISPR technology and stock prices discussions of $EDIT 966 subscribers in the EditasMedicine community. Unofficial - Editas Medicine Message Board on Reddit. Editas summary conference. GameStop Moderna Pfizer Johnson & Johnson AstraZeneca Walgreens Best Buy Novavax SpaceX Tesla. Welcome on /r/stocks! Don't hesitate to tell us about a ticker we should know about, market news or financial education. CRISPR technology and stock prices discussions of $EDIT Editas Medicine stock price target cut to $19 from $46 at Stifel Nicolaus. The company utilized 12K subscribers in the biotech_stocks community. La asociación combinará los sistemas de edición genómica CRISPR Cas12a de Editas con la tecnología de nanopartículas lipídicas (LNP) patentada de Genevant para dos Post your stock predictions and news. Posted by u/[Deleted Account] - 5 votes and 15 comments Welcome on /r/stocks! Don't hesitate to tell us about a ticker we should know about, market news or financial education. CAMBRIDGE, Mass. From my admittedly limited understanding of the sector, the two big players at the moment are CRISPR and Editas. CRISPR technology and stock Reddit iOS Reddit Android Reddit Premium About Reddit Advertise Blog Careers Press. Premium Explore Gaming Reddit iOS Reddit Android Reddit Premium About Reddit Advertise Blog Careers Press. Shearman effective June 2021 Posted by u/StockConsultant - 3 votes and 1 comment Like any pharmaceutical or bio tech stock, there are going to be times of major highs and nasty lows. Shearman, Ph. (EDIT) reports financial results and business updates for Q4 and full year 2023. The Editas study has been underway for about a year, and is supposed to go until 2024. I am long, and do not expect to sell for another 18 months. Backseat Investor is a new community that is focused on Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. QUICK VISUAL TECHNICAL ANALYSIS PREDICTIONS of my companies, that includes biotech, semiconductors, gene View community ranking In the Top 20% of largest communities on Reddit Editas Medicine Names Mark S. (Nasdaq: EDIT), a leading genome editing company, today announced Editas Medicine (Nasdaq: EDIT) announced significant progress towards its 2024 goals, including achieving in vivo preclinical proof of concept for hematopoietic stem and progenitor cell (HSPC) editing. That patient outcomes in terms of quality of life and reduced organ failures stemming from anemia are potential differentiators for their product over exa-cel (Vertex and CRISPR Me, I held Beam stock for several years as an early employee and became a millionaire. CRISPR technology and stock prices discussions Editas Medicine (EDIT) announced a strategic transition to focus exclusively on in vivo CRISPR-edited medicines, following recent breakthroughs in preclinical studies. 22K subscribers in the MemeStockMarket community. --- Nothing said here is financial advice. That said, if they can recruit another pharmaceutical partner (like CRSP and Vertex) they may be in a better position overall. For beginner advice, brokerage info, book recommendations, even advanced topics and more, please read our Wiki here. PT / 2:15 p. Editas Medicine is the exclusive licensee of Broad Institute’s Cas12a patent estate and Broad Institute and Harvard University’s Cas9 patent estates for human medicines. , a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. 75 per share). Editas attended the Barclay Global Health Conference last week and presented a good summary of the company's standing and some timelines/expectations of their clinical trials. Coins. Welcome to our dedicated page for Editas Medicine news (Ticker: EDIT), a resource for investors and traders seeking the latest updates and insights on Editas Medicine stock. ET by Tomi Kilgore. Stock is pretty well priced considering the growth opportunity in the software sector. CRISPR technology and stock prices discussions of $EDIT That appears to be the view that some shareholders are taking with Editas, creating downward pressure on the biotech's share price. Apart from Reddit, Seek¡ng Alpha is the only other website I’ll visit but it’s mostly for articles on macroeconomic data, trends, earnings announcements, and 22K subscribers in the MemeStockMarket community. 6K subscribers in the GrowthStocks community. (Nasdaq: EDIT) is a clinical-stage genome editing company committed to developing transformative genomic medicines to treat serious diseases. Editas Medicine (Nasdaq: EDIT), a leading gene editing company, has announced its participation in the 43rd Annual J. See our analysis on Editas Stock Chances of A Rise for more details. 9M subscribers in the StockMarket community. (Nasdaq: EDIT), a leading genome editing company, today announced that it named Lisa A. SOFI is still a high-risk, growth stock. I told GPT that this would be long-term, 30 years. Editas Medicine, Inc. Let's make some money with world-changing investments. This non-dilutive capital will support Editas Medicine's pipeline development and strategic priorities. (SPACS), Units, Warrants and the best DD on Reddit. Crypto 3. The company's President and CEO, Gilmore O'Neill, will deliver a presentation on Wednesday, January 15, 2025, at 11:15 a. Now, this is a place to speculate on meme 971 subscribers in the EditasMedicine community. Editas Medicine (EDIT) reported Q3 2024 financial results, highlighting a net loss of $62. 4% near 90. ) According to Jeff, whichever company he is talking about will be making a huge announcement soon. Editas Medicine (Nasdaq: EDIT), a clinical-stage gene editing company, has announced its participation in three major healthcare investor conferences. Share Add a Comment. But I was, and still am, looking for an announcement about positive clinical study results so far. m. 967 subscribers in the EditasMedicine community. D. And that growth isn’t always tech companies. ET in San Francisco, CA. Crypto 12K subscribers in the biotech_stocks community. Now, this is a place to speculate on meme Overall gene editing stocks provide a huge upside potential but may not provide returns for some time. Due Diligence on OAC / For Hims Merger - 3-400% Upside Editas Medicine extends collaboration with Bristol Myers Squibb for 2 years to advance alpha-beta T cell cancer therapies, Reddit Announces Second Quarter 2024 Results. Editas Medicine Message Board on Reddit. The company made progress in its reni-cel program for Sickle Cell Disease and Beta Thalassemia, with promising data shared and enrollment ongoing. I think this stock has the potential to reach 1500. 9K subscribers in the INTELLECTUALPROPERTY community. 970 subscribers in the EditasMedicine community. PRESS RELEASE January 2, 2020 at 9:00 AM EST 299 subscribers in the pippost community. CRISPR technology and stock prices discussions Editas CEO resigns — sending stock into free fall 👇👀🔥 https://stockinvest. CRISPR technology and stock prices discussions Open menu Open navigation Go to Reddit Home. 0 coins. I think Editas stock could move higher as it and other biotechs advance pipeline candidates that use CRISPR-Cas9. Last, I told it that it could only buy the stocks now, no 973 subscribers in the EditasMedicine community. CRISPR technology and stock prices discussions of $EDIT Editas has a partnership with Juno Therapeutics (JUNO), where Juno is researching therapies to treat cancer. Editas has a study underway for that very condition (LCA10. , Nov. You have found the place. Are SPACs the future of IPOs, or are they just a Reddit iOS Reddit Android Reddit Premium About Reddit Advertise Blog Careers Press. Just in: Editas also announced the appointment of its new chief scientific officer Mark S. Insiders Ownership 0. Crypto Editas Medicine (EDIT) reported Q3 2024 financial results, highlighting a net loss of $62. Sometimes, news of successful completion of a phase II study causes a huge rise in the stock. The Nobel Prize has been officially handed over I asked ChatGPT to invest $100,000 in common stocks/ETFs. Discussion of ARK Invest. , as the Company’s Executive Vice President and Chief Medical Officer, effective immediately. Michelle Robertson to remain with Company until August 16, 2023. CRISPR technology and stock prices discussions 984 subscribers in the EditasMedicine community. Welcome to /r/StockMarket! Our objective is to provide short and mid term trade ideas, market analysis 969 subscribers in the EditasMedicine community. by Honest-Ad-3522. (EDIT) stock discussion in Yahoo Finance's forum. Cheap stocks are cheap for a reason, even if you don’t know the reason or disagree with the market’s price. We are NOT in this for the short term gains (or losses) --- If you are a SOFI investor before the SPAC merger with IPOE and want an "OG SOFI Investor" flair, please message the Mods with proof of your holdings. I am actually thankfull to Scorpion. Check out our wiki to learn more! Editas Medicine (Nasdaq: EDIT) y Genevant Sciences han anunciado una colaboración y un acuerdo de licencia no exclusivo para desarrollar medicamentos de edición genética in vivo. Members Online Predictmedix AI Ready To Blast In AI-driven Healthcare With The Massive Achievements Of 2023(CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) Unofficial - Editas Medicine Message Board on Reddit. Interested parties can access a live webcast of Posted by u/StockConsultant - 1 vote and no comments 34K subscribers in the swingtrading community. Share your opinion and gain insight from other stock traders and investors. It will be volatile and stock performance will extremely dependent on the news and progress of studies and trials. Terms & Policies Copy link Go to stocks r/stocks • by Editas Medicine Inc. But please, read the sidebar rules before you post. Biotechnology & Pharmaceuticals Stock News & Analysis. Terms & Policies Go to stocks r/stocks • by luchins. editasmedicine comments sorted by Best Top New Controversial Q&A Add a Comment Posted by u/StockConsultant - 1 vote and 1 comment Business, Economics, and Finance. Sangamo Therapeutics was the first to perform in vivo gene editing in humans in 2017 ( link ) and Intellia Therapeutics dosed patients in 2020 for the first systemically delivered CRISPR in vivo gene editing Why? Editas licenses patents claimed by the Broad Institute for use of CRISPR-Cas9 in humans. The downside to a dividend-centric portfolio is you miss out on meteoric growth. Crypto Along with intellia, precision biosciences, editas, etc. 6K subscribers in the prnewswire community. , Dec. I sold all the stock and bought options for the same number of shares. 836M INVITAE CORPORATION (NVTA) 151. Premium Powerups Explore Gaming. Look at a 10 year chart on HD. (CRISPR, EDITAS) The potential upside over the next ten years I believe can be weighed against the Welcome on /r/stocks! Don't hesitate to tell us about a ticker we should know about, market news or financial education. I had about 60K Posted by u/throwaway9732121 - 23 votes and 25 comments Posted by u/author-pendragon - 9 votes and 8 comments Besides the stocks engaged in COVID treatments, there are many more biotech stocks to look at, and my today's analysis will cover the full sector and main players in it over the past month (in total, there are ~6600 biotech companies in the United States). Although there is an equal chance of a rise or a fall for EDIT based on its historical performance, given the momentum in gene 744 subscribers in the Docstocks community. CRISPR technology and stock prices discussions of $EDIT View community ranking In the Top 20% of largest communities on Reddit Gene Editing Race Between Editas and Vertex, CRISPR Heats Up Welcome on /r/stocks! Don't hesitate to tell us about a ticker we should know about, market news or financial education. Editas also aims to establish in vivo preclinical proof-of-concept for an undisclosed indication by year-end. , they are developing cures to genetic diseases. Let's go get it boyz!! No clickbait titles These stocks should go down less when there’s a market correction, which always always happens. Do your own DD and decide how much 737 subscribers in the Docstocks community. The deal includes up to 100% of Raging bull market is not a time to consider stocks at new lows. Editas Medicine To Present At The 38th Annual J. , as Chief Scientific Officer Editas Medicine (Nasdaq: EDIT) has announced a $57 million upfront cash payment from DRI Healthcare Trust in exchange for certain future license fees and payments under its Cas9 license agreement with Vertex Pharmaceuticals. The PR Newswire is a subreddit to share links to company, product, people, and other types of press Editas/Crispr they have a market cap in order of 1,5 billions. 50 23K subscribers in the MemeStockMarket community. CRISPR technology and stock prices discussions 16 votes, 26 comments. . It's stock price at the moment certainly reflects that as well. Posted by u/mosquitobird11 - 7 votes and 11 comments Business, Economics, and Finance. Mullen as President and Chief Executive Officer, and Lisa A Business, Economics, and Finance. us/l/P6ODp0EF8V Find the latest Editas Medicine, Inc. That means the company stands to receive royalties on any future therapies sold that use the gene-editing technique for treating humans. 25, 2022 at 7:05 a. CRISPR technology and stock prices discussions 971 subscribers in the EditasMedicine community. Check out our wiki to learn more! Posted by u/Anonymous-Green - 6 votes and 3 comments Reddit iOS Reddit Android Reddit Premium About Reddit Advertise Blog Careers Press. EDIT Stock Data Market Cap 382. Welcome on /r/stocks! Don't hesitate to tell us about a ticker we should know about, market news or financial Skip to main content. Morgan Healthcare Conference. The company is on track to present additional clinical data from the RUBY trial for sickle cell disease and the EdiTHAL trial for beta thalassemia by year-end. Crypto Posted by u/[Deleted Account] - 3 votes and 6 comments Editas also seems to have some cool cancer related stuff in the works. This story is repeated in basically every Feng Zhang/David Liu company and is reliable for the employees that keep moving from one of them to the next new one through the years from Editas->Beam->Prime->Aera Welcome to r/stocks!. Posted by u/[Deleted Account] - 3 votes and no comments It wasn't immediately apparent what sent the three genetics stocks soaring. Sort by: Best. Morgan Healthcare Conference . Now, this is a place to speculate on meme Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. View community ranking In the Top 5% of largest communities on Reddit. CRISPR technology and stock prices discussions of $EDIT 24K subscribers in the technicalanalysis community. This is a place to discuss Trading Stocks, Futures ETFs, Advanced Investment strategies, & more Posted by u/StockConsultant - 1 vote and no comments Editas Medicine and Vertex Pharmaceuticals Enter into Non-exclusive License Agreement for Cas9 968 subscribers in the EditasMedicine community. CRISPR technology and stock prices discussions of $EDIT 973 subscribers in the EditasMedicine community. Please direct all simple questions towards the stickied 6M subscribers in the stocks community. Too retarded to add any more DD, theres a lot of info out there, read it yourself. Swing Trading is an investment strategy generally characterized by a short time horizon, emphasis on 983 subscribers in the EditasMedicine community. QUICK VISUAL TECHNICAL ANALYSIS PREDICTIONS of my companies, that includes biotech, semiconductors, gene 16K subscribers in the ArkInvestorsClub community. 35%. , May 16, 2023 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. CRISPR technology and stock prices discussions Get the latest Editas Medicine, Inc. Editas plans to kick off a phase 1/2 study of EDIT-301 in treating sickle cell disease in 2021 as well. EDIT | Editas Medicine Announces Clinical Data Demonstrating Proof of Concept of EDIT-101 from Phase 1/2 BRILLIANCE Trial Editas will report initial results from its early-stage study evaluating EDIT-101 in treating rare genetic eye disease Leber congenital amaurosis around Sept. Lucera as Executive Vice President and Chief Financial Officer, effective May 17, 2023. CRISPR technology and stock prices discussions 967 subscribers in the EditasMedicine community. Open menu Open navigation Go to Reddit Home. Terms & Policies #EDIT Editas Medicine is oversoldstrong compressionpossible double-digit increase!!! 1. r/stocks A chip A close button. A place to discuss and share Technical Analysis in relation to price action. CRISPR technology and stock prices discussions 969 subscribers in the EditasMedicine community. At the same time, shares of Uniqure — another genetics stock — plunged after the Food and Drug Administration placed its hemophilia B clinical study on hold. It develops a proprietary gene editing platform based on Editas Medicine Stock (NASDAQ: EDIT) stock price, news, charts, stock research, profile. 119K subscribers in the StocksAndTrading community. Biotech and Pharma The Gene-Editing Industry Weighs In on Outlook at J. Valheim Genshin Reddit iOS Reddit Android Reddit Premium About Reddit Advertise Blog Careers Press. Editas also entered a license agreement with Vertex Pharmaceuticals for Cas9 gene editing 05/16/2023 - 04:30 PM . (EDIT) 551. Also, Editas has raised money from Bill Gates, Google Ventures and others. Is it a good move to invest in Editas Medicine? it had an huge spike cause the quarters results were good comments sorted February 25, 2021 at 7:00 AM EST Strengthened Leadership by Appointing James (Jim) C. Other times, similar news would result in If you find yourself up huge on an equity investment, switch to options. Editas is on track and looking 2. Crypto Posted by u/Anonymous-Green - 3 votes and 3 comments The dozen most overvalued stocks are: SunPower, Editas Medicine (EDIT), Redfin (RDFN), Tesla, Stitch Fix (SFIX), Ultragenyx Pharmaceutical Units, Warrants and the best DD on Reddit. 4K subscribers in the backseatinvestor community. Basically one person with sickle cell was treated with their drug CTX001 and the patient who previously required 15 blood transfusions per year was transfusion free for like 18 months. However, it seems to me that there seems to be very little correlation to any specific variable and the underlying stock's performance. The company achieved in vivo preclinical proof of concept for editing hematopoietic stem cells (HSCs) in non-human primates and demonstrated successful liver cell editing, marking November 9, 2020 at 9:00 AM EST. URI - I work in construction and think they are extremely well positioned in equipment rentals. (EDIT) stock quote, history, news and other vital information to help you with your stock trading and investing. I told it that it could not have more than 30 stocks or ETFs total. When it hit 300, I was up 200%. P. Stock Market News for Traders and Investors Posted by u/Sweet-Count2557 - 1 vote and no comments 1. Way less hyped, but they are back on track now. Float 82. If you want to watch for a decent play with large potential Elevate Bio was a gene editing company we built their facility who launched a separate company ALVR and has a huge potential for T cell therapies for immunocompromised patients often Posted by u/Lotuseliseracer - 1 vote and 11 comments Stock Market News Feed for Idea Generation Best viewed on PC with Reddit Enhancement Suite Use an Auto Reload Tab browser extension to refresh every 1 - 3 minutes. 09, 2020 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. CRSP just concluded small human trials. Do you think that the company is still relativley unknown and it has room grown from Stock Market News for Traders and Investors. CRISPR technology and stock prices discussions 2. 9K subscribers in the StockTitan community. " This is a group of investors who are LONG SoFi. Open comment sort options look at the stock price the last week. Yesterday I would have said VRTX, but that ship sailed this morning. QUICK VISUAL TECHNICAL ANALYSIS PREDICTIONS of my companies, that includes biotech, semiconductors, gene Posted by u/PhilJonesOnCorners - 1 vote and 4 comments Posted by u/Honest-Ad-3522 - 5 votes and 10 comments Posted by u/luchins - No votes and 3 comments Welcome on /r/stocks! Don't hesitate to tell us about a ticker we should know about, market news or financial education. Enjoy actual free discussion. CRISPR technology and stock prices discussions of $EDIT Editas Medicine Announces Positive Safety and Efficacy Data from the First Two Patients Treated in the RUBY Trial of EDIT-301 for the Treatment of Severe Sickle Cell Disease ir. QUICK VISUAL TECHNICAL ANALYSIS PREDICTIONS of my companies, that includes biotech, semiconductors, gene Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced the appointment of Erick J. The company achieved preclinical proof of concept for in vivo HBG1/2 editing in HSPCs using proprietary targeted LNP technology for sickle cell disease and beta thalassemia treatment. The TechCrunch of the stock world. 236M Editas Medicine Announces Clinical Achievements in the Development of EDIT-301 for Sickle Cell Disease I've got both CRSP and EDIT, but Editas is worth mentioning as the riskier of the two. If you want to invest in pharmaceutical companies there are so many better options. A subreddit about growth investing and growth stocks, feel free to discuss any companies/stocks that 742 subscribers in the Docstocks community. RIVN. On intellectual property. Track Editas Medicine Inc (EDIT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Stock Market News for Traders and Investors 1. They drove the value so down that i got tempted to purchase large qty of stock. But am more then happy if it reaches 70-80. ET in Boston, the Stifel 2024 Healthcare Conference on 22K subscribers in the technicalanalysis community. Good cash flow, enough cash on hand to pay down debt. I brought into Crispr companies early and now they are on an all time high. CRISPR technology and stock prices discussions So it seems like Editas is essentially trying to build their differentiation argument that the clinical results should go beyond just eliminating vaso-occlusive events. r/EditasMedicine: Unofficial - Editas Medicine Message Board on Reddit. Business, Economics, and Finance. 1 million ($0. If you're wondering why a stock moved a certain way, check out Finviz which aggregates the most news for almost every stock, but also see Reuters, and even Yahoo Finance. 05, 2020 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. Share your ideas and get valuable insights from the Find latest Editas Medicine Inc (EDIT) stock discussions and message board on Twitter, StocksTwits, Reddit, SeekingAlpha and other social media Find the latest Editas Medicine, Inc.